Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Pasche

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Ebiomedicine|May 27, 2019
Ca<sup>2+</sup> and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMFSambad Sharma, Shih-Ying Wu, Hugo Jimenez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Genetic/familial high-risk assessment: breast and ovarianMary B Daly, Jennifer E Axilbund, Eileen Bryant, et al.
The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
The Lancet. Oncology|May 13, 2017
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trialAngela Alistar, Bonny B Morris, Rodwige Desnoyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2010
Genetic/familial high-risk assessment: breast and ovarianMary B Daly, Jennifer E Axilbund, Saundra Buys, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Colorectal Cancer Screening Clinical Practice GuidelinesBernard Levin, James S Barthel, Randall W Burt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Cancer Genetics|March 21, 2012
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583Sari Tuupanen, Jian Yan, Mikko Turunen, et al.
Journal of Hematology & Oncology|May 6, 2017
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stagesMeng Yang, Umit Topaloglu, W Jeffrey Petty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Ebiomedicine|May 27, 2019
Ca<sup>2+</sup> and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMFSambad Sharma, Shih-Ying Wu, Hugo Jimenez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Genetic/familial high-risk assessment: breast and ovarianMary B Daly, Jennifer E Axilbund, Eileen Bryant, et al.
The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
The Lancet. Oncology|May 13, 2017
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trialAngela Alistar, Bonny B Morris, Rodwige Desnoyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2010
Genetic/familial high-risk assessment: breast and ovarianMary B Daly, Jennifer E Axilbund, Saundra Buys, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Colorectal Cancer Screening Clinical Practice GuidelinesBernard Levin, James S Barthel, Randall W Burt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Cancer Genetics|March 21, 2012
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583Sari Tuupanen, Jian Yan, Mikko Turunen, et al.
Journal of Hematology & Oncology|May 6, 2017
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stagesMeng Yang, Umit Topaloglu, W Jeffrey Petty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Pageof 10